Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tousseyn

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
Blood|February 18, 2011
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphomaKatrien Van Roosbroeck, Luk Cox, Thomas Tousseyn, et al.
Human Molecular Genetics|October 16, 2012
Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiencyRobin Lemmens, Alessandra Maugeri, Hans W M Niessen, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2016
Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndromeLeen Moens, Glynis Frans, Barbara Bosch, et al.
International Journal of Cancer|May 21, 2013
Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotypeSylvia Hartmann, Thomas Tousseyn, Claudia Döring, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2023
Biallelic mutations in the CFHR genes underlying atypical hemolytic uremic syndrome in a patient with catastrophic adult-onset Still's disease and recurrent macrophage activation syndrome: A case reportLuna Dillemans, Youri Bekhuis, Albrecht Betrains, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2020
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Plos One|November 19, 2013
Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?Sylvia Hartmann, Claudia Döring, Christina Jakobus, et al.
Journal of Clinical Immunology|July 13, 2022
A Novel Homozygous Stop Mutation in IL23R Causes Mendelian Susceptibility to Mycobacterial DiseaseFrederik Staels, Flaminia Lorenzetti, Kerstin De Keukeleere, et al.
Journal of Clinical Immunology|January 19, 2020
Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys MutationGiorgia Bucciol, Bethany Pillay, Jose Casas-Martin, et al.
Genes, Chromosomes & Cancer|May 25, 2022
Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosityStefania Tuveri, Koen Debackere, Lukas Marcelis, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Blood|February 18, 2011
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphomaKatrien Van Roosbroeck, Luk Cox, Thomas Tousseyn, et al.
Human Molecular Genetics|October 16, 2012
Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiencyRobin Lemmens, Alessandra Maugeri, Hans W M Niessen, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2016
Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndromeLeen Moens, Glynis Frans, Barbara Bosch, et al.
International Journal of Cancer|May 21, 2013
Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotypeSylvia Hartmann, Thomas Tousseyn, Claudia Döring, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2023
Biallelic mutations in the CFHR genes underlying atypical hemolytic uremic syndrome in a patient with catastrophic adult-onset Still's disease and recurrent macrophage activation syndrome: A case reportLuna Dillemans, Youri Bekhuis, Albrecht Betrains, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2020
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Plos One|November 19, 2013
Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?Sylvia Hartmann, Claudia Döring, Christina Jakobus, et al.
Journal of Clinical Immunology|July 13, 2022
A Novel Homozygous Stop Mutation in IL23R Causes Mendelian Susceptibility to Mycobacterial DiseaseFrederik Staels, Flaminia Lorenzetti, Kerstin De Keukeleere, et al.
Journal of Clinical Immunology|January 19, 2020
Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys MutationGiorgia Bucciol, Bethany Pillay, Jose Casas-Martin, et al.
Genes, Chromosomes & Cancer|May 25, 2022
Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosityStefania Tuveri, Koen Debackere, Lukas Marcelis, et al.
Pageof 18